Why Ginkgo Bioworks is number 19 on CNBC's Disruptor 50 list

2:13 PM ET Thu, 16 May 2019

Jason Kelly, Ginkgo Bioworks CEO, joins 'The Exchange' to discuss how his company makes 'made-to-order' microbes and how it's disrupting the industry.